A first-in-human phase I study of liposomal RNA vaccines for newly diagnosed adult O6-methylguanine-DNA methyltransferase (MGMT) unmethylated glioblastoma (GBM) have recently begun recruiting. The gene discussed is MGMT; the disease is glioblastoma.